SkinHealth Systems Inc.
SKINConsumer DefensiveNASDAQHousehold & Personal Products
Scan Results
Daily timeframeSkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa,. Valued at $70.9M, SKIN is a micro-cap name in its sector. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.
Market Cap
$70.9M
Beta
1.05
P/E (TTM)
—
P/E (Fwd)
2.85
EPS (TTM)
$-4.60
EPS (Fwd)
$3.82
ROE
-43.9%
ROA
-0.5%
Cash
$204.1M
Total Debt
$367.0M
Free CF
$27.5M
52W Change
-62.7%
Annual Financials
Cash vs Debt
Where SKIN stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, SKIN finished 801.71% above its 150-day moving average ($1.17) and 786.55% above its 200-day moving average ($1.19). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SKIN overbought or oversold?
At the October 20, 2026 close, SKIN's RSI(14) was 85.0, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
SkinHealth Systems Inc. carries $367.0M in total debt against $204.1M in cash reserves — debt is roughly 1.8x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $27.5M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -43.9%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has been uneven over recent years, ranging from $260.1M to $300.8M.
Investors considering SkinHealth Systems Inc. should weigh the typical risks associated with SKIN's sector, size, and financial profile against their own risk tolerance and investment objectives. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence SkinHealth Systems Inc.'s trajectory.